ESR1 mutant breast cancers show elevated basal cytokeratins and immune activation
Zheqi Li(University of Pittsburgh), Steffi Oesterreich(University of Pittsburgh)
Cited by 72
Related Papers
Mutation site and context dependent effects of ESR1 mutation in genome-edited breast cancer cell models
|Breast Cancer Research|2017|161
Key regulators of lipid metabolism drive endocrine resistance in invasive lobular breast cancer
|Breast Cancer Research|2018|103
Hotspot <i>ESR1</i> Mutations Are Multimodal and Contextual Modulators of Breast Cancer Metastasis
|Cancer Research|2022|80
Upregulation of IRS1 Enhances IGF1 Response in Y537S and D538G ESR1 Mutant Breast Cancer Cells
|Endocrinology|2017|45
Spatial molecular profiling of mixed invasive ductal and lobular breast cancers reveals heterogeneity in intrinsic molecular subtypes, oncogenic signatures, and mutations
|Proceedings of the National Academy of Sciences|2024|16